Pediatric Medication Therapy Management Trial

Optimizing the Clinical Management of Polypharmacy for Children With Medical Complexity: The Pediatric Medication Therapy Management (pMTM) Trial

The purpose of this study is to evaluate whether an intervention called Pediatric Medication Therapy Management (pMTM) improves the identification and management of medication-related problems among children with medical complexity and polypharmacy.

Patients and their parents who meet the study eligibility requirements will be invited to participate in the study. After being informed about the study and potential risks, all patients and their parents giving written informed consent (and assent, when appropriate) will be randomized in a 1:1 ratio to usual care or to the Pediatric Medication Therapy Management (pMTM) intervention.

Inclusion Criteria:

• 2-18 years old
• ≥1 complex chronic condition (CCC)
• ≥5 current medications (including prescription, as needed, and over-the-counter medications)
• Receives primary care at Children's Hospital Colorado

Exclusion Criteria:

• Non-English speaking
• Sibling or family member already enrolled in this study